Atul Bioscience, a wholly-owned subsidiary of Atul, received Certificate of Suitability (CEP) approval for Venlafaxine hydrochloride from European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe.
May 2024: ABL received CEP approval for Venlafaxine hydrochloride from EDQM